Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab and Oral Chemotherapy in HER2+ Stage I Breast Cancer
NCT04922008Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Jul 2021
- Primary completion
- Jun 2024
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by Fudan University. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04922008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04922008.